Once-daily LDL cholesterol-smashing pill gets FDA approval

AI justification

FDA approval of accessible oral cholesterol drug advances public health and SDG 3 | The FDA's approval of an oral LDL cholesterol-lowering drug represents a significant advancement in cardiovascular health, directly supporting SDG 3 (Good Health and Well-being). The innovation improves patient accessibility and adherence compared to injectable alternatives, with no identified ethical violations or negative impacts in this action.